Zenith Drugs Limited (NSE:ZENITHDRUG)

Zenith Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	2.63	88.03	2.79	30.01	18.48
Cash & Short-Term Investments	2.63	88.03	2.79	30.01	18.48
Cash Growth	-97.01%	3053.96%	-90.70%	62.37%	3.83%
Accounts Receivable	605.77	673.95	493.11	320.68	233.82
Other Receivables	-	-	-	0.68	-
Receivables	726.02	676.32	496.32	321.36	233.82
Inventory	396.12	257.58	236.73	121.31	68.32
Prepaid Expenses	-	-	-	3.37	0.21
Other Current Assets	26.99	111.34	103.38	59.25	37.67
Total Current Assets	1,152	1,133	839.22	535.3	358.49
Property, Plant & Equipment	431.86	152.42	116.98	131.23	92.06
Other Intangible Assets	1.76	0.07	0.1	0.12	0.13
Long-Term Deferred Tax Assets	0.12	0.66	-	-	-
Other Long-Term Assets	29.27	-0	0	19.2	14.79
Total Assets	1,615	1,350	979.25	685.85	465.47
Accounts Payable	401.84	426.31	508.74	346.81	202.64
Accrued Expenses	-	5.22	11.28	10.7	9.34
Short-Term Debt	357.73	140.06	157.89	40.57	52.03
Current Portion of Long-Term Debt	-	20.74	19.6	51.81	30.04
Current Income Taxes Payable	-	38.91	17.58	13.34	3.56
Other Current Liabilities	33.46	10.22	1.45	2.55	2.14
Total Current Liabilities	793.03	641.47	716.54	465.78	299.75
Long-Term Debt	127.96	85.59	83.63	95.71	72.75
Long-Term Deferred Tax Liabilities	-	-	1.72	2.63	3.08
Other Long-Term Liabilities	-	-0	-	-	0
Total Liabilities	920.98	727.05	801.89	564.79	375.94
Common Stock	171.49	171.49	4	4	4
Additional Paid-In Capital	-	306.58	2	2	2
Retained Earnings	-	144.57	171.22	114.91	83.53
Comprehensive Income & Other	522.3	-	-	-	-
Total Common Equity	693.79	622.64	177.22	120.91	89.53
Minority Interest	-	0.68	0.15	0.15	-
Shareholders' Equity	693.79	623.33	177.36	121.06	89.53
Total Liabilities & Equity	1,615	1,350	979.25	685.85	465.47
Total Debt	485.68	246.39	261.12	188.09	154.81
Net Cash (Debt)	-483.05	-158.36	-258.33	-158.08	-136.33
Net Cash Per Share	-28.20	-9.23	-21.53	-13.17	-11.36
Filing Date Shares Outstanding	17.13	17.15	12	12	12
Total Common Shares Outstanding	17.13	17.15	12	12	12
Working Capital	358.74	491.8	122.68	69.52	58.74
Book Value Per Share	40.50	36.31	14.77	10.08	7.46
Tangible Book Value	692.03	622.57	177.12	120.79	89.39
Tangible Book Value Per Share	40.40	36.30	14.76	10.07	7.45
Land	-	-	-	27.47	9.49
Buildings	-	-	-	52.8	52.18
Machinery	-	-	-	87.45	80.25
Construction In Progress	-	-	-	26.62	-

Updated May 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.